As of Apr 2024 ยท from CURLMIX Preferred Stock 2 ยท pre-money + amount raised, not a traded price
Total raised
$5,811,959
Across 2 rounds since 2021
Latest share price
$3.29
CURLMIX Preferred Stock 2 offering price
Financials
FY2019โFY2024 ยท from SEC filings ยท hover any figure for its source
$5.3M
โ$1.0M
2019
$5.6M
$899K
2020
$4.6M
$3.2M
2021
$8.6M
โ$4.6M
2022
$5.5M
โ$3.6M
2023
$4.4M
โ$2.7M
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$5,326,590
$5,559,807
$4,596,871
$8,587,650
$5,527,835
$4,449,101
Cost of goods sold
$1,758,804
$1,558,244
$966,781
$4,046,891
$1,735,539
$1,692,281
Gross margin
67%
72%
79%
53%
69%
62%
Net income
-$1,048,399
$898,854
$3,179,692
-$4,569,819
-$3,552,313
-$2,703,668
Taxes paid
$0
$0
$0
$0
$477,024
$176,298
Balance sheet
Cash
$442,628
$252,687
$187,538
$224,868
$2,039,381
$2,064,886
Accounts receivable
$0
$0
$0
$0
$5,100
$30,974
Total assets
$910,833
$1,038,352
$904,462
$3,738,277
$3,293,708
$2,901,162
Short-term debt
$879,323
$1,602,742
$1,240,122
$2,868,360
$4,417,519
$3,765,929
Long-term debt
$0
$200,000
$0
$4,483,590
$9,201,992
$8,407,840
Total liabilities
$879,323
$1,802,742
$1,240,122
$7,351,950
$13,619,510
$12,173,769
Other
Headcount
โ
36
36
24
โ
9
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.